Drug shortages plague hematology, but preparedness helpsJuly 18, 2022CLLALLHodgkin LymphomaMixed TopicsBusiness of MedicineB Cell LymphomaMantle Cell Lymphoma
Third-generation Black woman physician makes cancer research historyMay 24, 2022Mixed TopicsALLB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaDiversity in MedicineAML
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
New trials in lymphoma and MM: Could your patient benefit?November 10, 2021DLBCLMantle Cell LymphomaB Cell Lymphoma
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
New inhibitor shows promise in previously failed B-cell malignanciesMarch 12, 2021CLLMantle Cell Lymphoma
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesDLBCLAggressive LymphomasALLAMLAnemiaCLL
Hepatitis screening now for all patients with cancer on therapyAugust 6, 2020Patient & Survivor CareHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaB Cell LymphomaAggressive Lymphomas
COVID-19: Experts hasten to head off mental health crisisApril 23, 2020COVID-19 UpdatesMantle Cell LymphomaMixed Topics
Experts break down latest CAR T-cell advances in lymphomaJanuary 22, 2020B Cell LymphomaCellular TherapyMantle Cell Lymphoma
LOXO-305: Next-gen BTK inhibitor safe and effective in B-cell malignanciesDecember 20, 2019Mantle Cell LymphomaB Cell LymphomaCLL
Some MCL patients can safely stop venetoclax-ibrutinib, study suggestsDecember 14, 2019Mantle Cell LymphomaB Cell Lymphoma
